Scout | Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33

This opportunity is no longer accepting applications.

grant

Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

This grant opportunity seeks applications to further develop technologies or platforms that enhance predictive, diagnostic, and therapeutic solutions for heart, lung, blood, and sleep disorders. It targets projects that have already overcome major feasibility challenges, with supportive preliminary data, but need more development and validation. Suitable projects should accelerate or transform…

Source

Agency: National Institutes of Health

Sub-agency: National Heart, Lung, and Blood Institute

Award

Award Ceiling: $300,000

Funding Amount: $300,000

Dates

Opportunity Released: January 24, 2022

Open for Submission: January 24, 2022

Submission Deadline: December 20, 2024

Application Window Closes: December 20, 2024

Keywords

enabling technologies

transformative platforms

heart diseases

lung disorders

blood disorders

sleep disorders

predictive products

diagnostic products

therapeutic products

HLBS-related disorders

NHLBI Catalyze program

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers